Drug Pricing and Political Shifts

This chapter examines recent drug pricing legislation, particularly the government's limited ability to negotiate medication prices and the capping of insulin costs. It further explores the political ramifications for Democratic figures like Kamala Harris and Pete Buttigieg amid uncertainties regarding the current administration’s popularity. Additionally, the chapter critiques the ideological shifts of political figures and highlights the complexities within the Democratic Party as it navigates pressing national issues.